miR‐1254 inhibits progression of glioma in vivo and in vitro by targeting CSF‐1

por Li, Xin, Kong, Shiqi, Cao, Yingxiao
Publicado 2020

CDK4/6 inhibition suppresses tumour growth and enhances the effect of temozolomide in glioma cells

por Cao, Yingxiao, Li, Xin, Kong, Shiqi, Shang, Shuling, Qi, Yanhui
Publicado 2020

MiR‐3116 sensitizes glioma cells to temozolomide by targeting FGFR1 and regulating the FGFR1/PI3K/AKT pathway

por Kong, Shiqi, Cao, Yingxiao, Li, Xin, Li, Zhenzhong, Xin, Yuling, Meng, Yan
Publicado 2020

miR‐152‐5p suppresses glioma progression and tumorigenesis and potentiates temozolomide sensitivity by targeting FBXL7

por Kong, Shiqi, Fang, Yanwei, Wang, Bingqian, Cao, Yingxiao, He, Runzhi, Zhao, Zongmao
Publicado 2020

Lestaurtinib potentiates TRAIL‐induced apoptosis in glioma via CHOP‐dependent DR5 induction

por Cao, Yingxiao, Kong, Shiqi, Xin, Yuling, Meng, Yan, Shang, Shuling, Qi, Yanhui
Publicado 2020